drugset / Trial / NCT03538938

Improving Quitline Support Study

NCT03538938

RandomizedFactorialSingle-blindTreatment

Summary

This study seeks to evaluate ways to improve outcomes for low-education, uninsured or Medicaid-eligible smokers who do not successfully quit with standard telephone quit line treatment. The study will use an efficient factorial study design to evaluate four evidence-based strategies to improve follow-up care offered by the Wisconsin Tobacco Quit Line (WTQL) to socioeconomically disadvantaged callers who report smoking four months following initial WTQL treatment comprising a single counseling call and 2-week supply of a single nicotine replacement therapy. These strategies include: increasing the intensity of nicotine replacement medication (among those medically cleared to use such medications), increasing the intensity of WTQL counseling, helping callers enroll in an evidence-based smoking cessation texting support program (SmokefreeTXT), and offering moderate financial incentives for engagement in counseling and SmokefreeTXT.

Timeline

Start
2018-06-07
Primary completion
2023-08-15
Completion
2023-08-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown 2 mg
Subject Nicotine Unknown 4 mg
Subject Nicotine Unknown 14 mg
Subject Nicotine Unknown 21 mg

Indications